Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2010

View Archived Issues

Dengue virus therapy AVI-6006 shows promise in animal models

Intranasal GI.1 norovirus virus-like particle vaccine is safe and efficacious in healthy volunteers

Quadrivalent Fluzone QIV is as safe and immunogenic as trivalent flu vaccines

AN-3661 is efficacious against Plasmodium infections in mice

Marina Biotech receives approval for CEQ-508 trial in familial adenomatous polyposis

Advanced Life Sciences enters into CRADA to advance Restanza for malaria

Bayer Schering Pharma claims new neutrophil elastase inhibitors

Bristol-Myers Squibb and Simcere to jointly develop BMS-817378

FDA approves Cymbalta for management of chronic musculoskeletal pain

New cytotoxic agents described for colon cancer therapy

Provectus plans course of action for approval of PV-10 in Australia

Advaxis and NCI enter into CRADA to develop Listeria vaccines

Shire provides update on progress of third quarter 2010

Italian scientists present new inhibitors of HCV NS5B

Phase III data reported on crofelemer for diarrhea in HIV-infected persons on antiretroviral therapy

Sanofi-aventis presents new inhibitors of PDE7 and/or PDE8

Boehringer Ingelheim identifies new reverse transcriptase inhibitors

Alnylam grants property license to Tekmira for TKM-Ebola

Nicotine vaccine NIC-002 enters phase II study

FDA approves once-daily Kombiglyze XR tablets for type 2 diabetes

FDA clears Vitros intact parathyroid hormone assay

Primary endpoint met in phase IIa vidofludimus trial in inflammatory bowel disease

Kuros regains rights to KUR-112, KUR-212 and KUR-213

Phase IIb data reported on LIPO-102 for selective nonablative fat reduction

BMK.1 inhibitor XMD-8-92 inhibits tumor growth in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...